RXST: RxSight, Inc.
About
RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.
Current Value
$45.081 Year Return
Current Value
$45.081 Year Return
Key Details
Market Cap
$1.82B
P/E Ratio
-55.05
1Y Stock Return
62.89%
1Y Revenue Growth
67.51%
Dividend Yield
0.00%
Price to Book
6.6
Strategies that include RXST
Stock's related to RXST
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ALKT | 44.25% | $3.80B | +65.83% | 0.00% |
| RDNT | 40.98% | $5.91B | +151.89% | 0.00% |
| UBER | 39.88% | $145.57B | +26.03% | 0.00% |
| VCEL | 39.40% | $2.76B | +55.60% | 0.00% |
| ATRO | 39.28% | $575.48M | +5.29% | 0.00% |
| CROX | 38.56% | $5.71B | +5.81% | 0.00% |
| OFIX | 38.38% | $715.75M | +67.38% | 0.00% |
| PAR | 38.23% | $2.72B | +98.12% | 0.00% |
| BCRX | 37.94% | $1.49B | +41.37% | 0.00% |
| TY | 37.62% | - | - | 3.32% |
| MNDY | 37.55% | $12.81B | +50.66% | 0.00% |
| LAW | 37.30% | $325.90M | -3.37% | 0.00% |
| TMDX | 37.21% | $2.78B | +22.14% | 0.00% |
| YOU | 37.07% | $2.50B | +34.63% | 1.10% |
| FICO | 36.51% | $55.62B | +116.55% | 0.00% |
| PBPB | 36.50% | $293.68M | +4.36% | 0.00% |
| PLRX | 36.31% | $778.32M | -9.55% | 0.00% |
| NCMI | 35.82% | $641.63M | +63.48% | 0.00% |
| CSTL | 35.04% | $808.57M | +48.97% | 0.00% |
| OMER | 35.02% | $349.44M | +258.93% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| EXEL | -0.04% | $9.83B | +62.16% | 0.00% |
| NNVC | -0.11% | $19.66M | +25.69% | 0.00% |
| PGR | 0.11% | $149.10B | +57.29% | 0.45% |
| HAL | -0.20% | $26.77B | -20.26% | 2.20% |
| COP | 0.21% | $130.16B | -1.63% | 2.59% |
| MRO | -0.21% | $16.08B | +13.59% | 1.53% |
| WTW | 0.26% | $30.98B | +26.60% | 1.13% |
| RYAN | -0.26% | $8.81B | +55.63% | 0.62% |
| MOH | -0.27% | $16.16B | -21.56% | 0.00% |
| BEST | 0.36% | $31.65M | +3.88% | 0.00% |
| CHRW | -0.36% | $12.89B | +32.52% | 2.24% |
| BP | 0.37% | $77.24B | -18.61% | 6.32% |
| NTZ | 0.39% | $47.64M | -30.94% | 0.00% |
| CNQ | 0.42% | $71.04B | +1.89% | 6.81% |
| THS | 0.43% | $1.72B | -17.36% | 0.00% |
| MSDL | 0.45% | $1.83B | +0.66% | 7.26% |
| PFE | -0.48% | $142.24B | -17.16% | 6.73% |
| EG | -0.49% | $15.92B | -8.98% | 2.02% |
| HIG | 0.51% | $33.87B | +51.09% | 1.60% |
| HUM | 0.61% | $33.45B | -45.22% | 1.25% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| DADA | -18.01% | $367.07M | -63.71% | 0.00% |
| PRPO | -16.41% | $9.10M | -13.65% | 0.00% |
| NEUE | -15.98% | $40.93M | -34.13% | 0.00% |
| GIS | -15.60% | $34.85B | -2.91% | 3.78% |
| MNR | -15.39% | $1.66B | -10.71% | 15.90% |
| STG | -14.88% | $35.67M | +7.92% | 0.00% |
| BMY | -11.33% | $118.10B | +20.11% | 4.09% |
| CYCN | -11.27% | $4.77M | -16.19% | 0.00% |
| NOC | -11.11% | $71.54B | +4.23% | 1.60% |
| DK | -10.78% | $1.14B | -34.04% | 5.64% |
| HUSA | -10.67% | $16.69M | -11.56% | 0.00% |
| GILD | -10.45% | $109.36B | +17.49% | 3.47% |
| LTM | -10.45% | $8.51B | -100.00% | <0.01% |
| XOM | -10.27% | $521.39B | +13.56% | 3.22% |
| COR | -9.87% | $47.48B | +21.20% | 0.86% |
| SNY | -9.72% | $120.34B | +3.11% | 4.25% |
| LRN | -9.71% | $4.43B | +74.97% | 0.00% |
| HRL | -9.68% | $16.30B | -8.38% | 3.81% |
| CB | -9.64% | $114.43B | +26.00% | 1.24% |
| OCX | -9.55% | $42.93M | -36.09% | 0.00% |
ETF's related to RXST
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| PTH | 52.56% | $143.31M | 0.6% |
| XHE | 51.88% | $213.41M | 0.35% |
| PFUT | 46.71% | $326.69M | 0.64% |
| IPO | 45.86% | $157.08M | 0.6% |
| FFTY | 45.83% | $67.59M | 0.8% |
| XT | 45.49% | $3.38B | 0.46% |
| VOT | 44.76% | $15.26B | 0.07% |
| SKYY | 44.30% | $3.41B | 0.6% |
| FDN | 44.19% | $6.98B | 0.51% |
| ESGV | 44.19% | $9.91B | 0.09% |
| MILN | 44.18% | $126.77M | 0.5% |
| SUSA | 44.17% | $3.77B | 0.25% |
| IWO | 43.99% | $12.56B | 0.24% |
| NUHY | 43.91% | $89.47M | 0.31% |
| ISCG | 43.77% | $640.00M | 0.06% |
| IHAK | 43.74% | $916.89M | 0.47% |
| FNY | 43.59% | $372.31M | 0.7% |
| QQQE | 43.47% | $1.24B | 0.35% |
| FPX | 43.29% | $797.15M | 0.59% |
| ARKF | 43.25% | $1.09B | 0.75% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| FTGC | 0.29% | $2.17B | 1.02% |
| CLOI | 0.42% | $715.40M | 0.4% |
| YEAR | -0.53% | $1.13B | 0.25% |
| XHLF | -0.58% | $874.27M | 0.03% |
| SGOV | -0.59% | $27.53B | 0.09% |
| FTSM | -1.01% | $6.08B | 0.45% |
| CORN | -1.43% | $61.12M | 0.2% |
| WEAT | 1.62% | $120.27M | 0.28% |
| DBC | -1.76% | $1.39B | 0.87% |
| SEIX | 1.82% | $268.81M | 0.62% |
| BCD | 1.85% | $245.02M | 0.3% |
| FMF | -1.88% | $244.61M | 0.95% |
| DBA | -2.01% | $755.88M | 0.93% |
| SOYB | 2.02% | $27.32M | 0.22% |
| DRLL | 2.04% | $336.91M | 0.41% |
| BILZ | 2.06% | $563.02M | 0.14% |
| UNG | 2.07% | $908.80M | 1.06% |
| IBDP | 2.09% | $2.11B | 0.1% |
| HDRO | -2.14% | $164.26M | 0.3% |
| IXC | 2.71% | $2.20B | 0.41% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -34.14% | $195.31M | 0.85% |
| BTAL | -32.54% | $388.04M | 1.43% |
| TAIL | -27.93% | $67.98M | 0.59% |
| USDU | -16.48% | $201.97M | 0.5% |
| CCOR | -11.99% | $109.04M | 1.18% |
| XBIL | -11.82% | $637.70M | 0.15% |
| UUP | -11.54% | $309.25M | 0.77% |
| ULST | -9.69% | $535.47M | 0.2% |
| KMLM | -8.42% | $353.87M | 0.9% |
| CTA | -7.39% | $350.27M | 0.78% |
| TPMN | -7.37% | $40.60M | 0.65% |
| USCI | -7.13% | $185.47M | 1.07% |
| EQLS | -7.12% | $76.08M | 1% |
| IYK | -6.57% | $1.30B | 0.4% |
| DBO | -6.46% | $217.57M | 0.77% |
| DBE | -6.15% | $50.13M | 0.77% |
| HIGH | -5.01% | $302.78M | 0.51% |
| BOXX | -3.46% | $4.43B | 0.1949% |
| PDBC | -3.26% | $4.40B | 0.59% |
| GSG | -3.25% | $914.42M | 0.75% |
News
SeekingAlpha
Baird Small/Mid Cap Growth portfolio increased +6.9% in 3Q, net of fees, compared to the +7.0% increase in our primary benchmark, the Russell 2500 Growth Index.
Yahoo
Last week, you might have seen that RxSight, Inc. ( NASDAQ:RXST ) released its third-quarter result to the market. The...
SeekingAlpha
RxSight, Inc. (NASDAQ:RXST) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsOliver Moravcevic - Vice President, Investor...
Yahoo
RxSight Inc (RXST) reports a 59% revenue increase and improved gross margins, while navigating challenges and expanding its market presence.
Yahoo
RxSight (RXST) delivered earnings and revenue surprises of -100% and 0.47%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Yahoo
ALISO VIEJO, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended September 30, 2024. Key Quarterly Highlights Reported third quarter 2024 revenue of $35.3 million, an increase of 59% compared to the third quarter of 2023, reflecting: The sale of 24,554 Light Adjustable Lenses (LAL™/LAL
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.